Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial

BJ Slotman, C Faivre-Finn, H van Tinteren, A Keijserd, John Praag, J Knegjens, M Hatton, I van Dam, A van der Leest, B Reymen, J Stigt, K Haslett, D Tripathi, EF Smit, S Senan

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Scopus)
25 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)150-153
Number of pages4
JournalLung Cancer
Publication statusPublished - 2017

Research programs

  • EMC MM-03-32-04

Cite this